TARA
Protara Therapeutics Inc
2.60$
-2.9%
vs. previous close
Closing price · As of: Oct 6, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | -100.0% | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | +71.9% | – | – | – | -0.5% | -83.8% | +15.6% | +4.1% | +445.5% | -74.5% | +0.0% | -22.4% | +0.0% | +1.2% | – | – | +18.1% | -10.2% | +5.7% | -3.2% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -107.5% | – | – | – | -150.0% | – | – | – | – | – | – | |
| – | -8.3% | -4.3% | -8.5% | +165.8% | -69.0% | +26.8% | -32.2% | -14.7% | -52.9% | -2.8% | -8.5% | +11.3% | +189.9% | -3.8% | -19.4% | +13.2% | +30.6% | +92.8% | -16.4% | -30.5% | -0.6% | +29.5% | -41.5% | +12.4% | +43.9% | +3.1% | +40.9% | -14.2% | +2.6% | +20.1% | -16.7% | +26.4% | +17.7% | -3.7% | +17.7% | -10.9% | +36.8% | +2.7% | +25.9% | – | |
| – | +4.7% | -8.2% | -5.8% | -6.2% | +20.8% | -3.8% | -2.2% | +1.2% | -86.9% | +51.2% | -1.8% | +184.1% | -49.8% | +1,026.2% | -32.4% | +9.8% | +0.7% | +23.3% | +5.6% | -2.4% | -7.7% | -9.9% | +0.3% | -19.8% | +11.0% | -8.3% | +6.6% | -8.4% | +4.0% | -12.0% | +4.2% | -0.3% | +13.0% | +3.4% | +16.9% | -11.1% | +15.2% | +1.9% | +5.0% | – | |
| – | -4.2% | -5.7% | -7.6% | +105.5% | -54.6% | +14.0% | -21.5% | -7.6% | -69.6% | +8.6% | -6.5% | +64.8% | -208.5% | – | -28.5% | +11.0% | +11.1% | +51.6% | -5.8% | -15.3% | -5.0% | +5.7% | -19.9% | -8.4% | +395.5% | -75.4% | +24.7% | -11.9% | +3.2% | +6.6% | -9.4% | +15.7% | +16.1% | -1.3% | +17.4% | -11.0% | +29.3% | +2.4% | +19.4% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -497.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.0% | -25.0% | +66.7% | +60.0% | +25.0% | -10.0% | +22.2% | +2.7% | +10.6% | -16.0% | -30.5% | -27.4% | +98.1% | -5.4% | +26.6% | – | – | – | +78.4% | -1.8% | – | – | -15.6% | -20.8% | -60.9% | +542.1% | – | – | – | – | – | – | – | – | -6.0% | -7.6% | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -489.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -145.5% | – | +4,200.0% | -1,650.7% | – | +171.4% | -39.5% | -2.2% | +11.6% | -15.9% | -1,952.3% | – | -104.2% | – | – | +5.0% | – | – | – | – | +8,125.0% | -106.0% | – | – | – | – | – | – | – | -97.6% | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -489.2% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | -456.7% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.